Skip to the page

Data / Research funding / Vaxine Pty LTD

Vaxine Pty LTD: 1 NIH award ($2.7M), fiscal years 2021 to 2026

Vaxine Pty LTD in Bedford Park is funded under 1 NIH award ($2.7M) in the NIH and NSF award files, read 2026-11-03. NIH fiscal years 2021 to 2025; NSF fiscal years 2022 to 2026.

SpecStream is the live web data engine for teams and agents. It reads the NIH and NSF award files each time the agencies update them, and this page is that reading, joined to the open federal funding opportunities on Grants.gov. Ask for the awards you track by topic, organization or state and new awards arrive in your sheet, CRM, Slack or agent as the agencies publish them.

NIH institution profile
10017775
Note
NIH gives no UEI for this institution, so NSF awards are not matched.

Awards

1 awards in the window.

AwardAgencyInstitute or divisionFiscal yearAmount in windowStartEndPrincipal investigatorSource
Adjuvant Development in the context of a vaccine to protect against tuberculosisNIHNational Institute of Allergy and Infectious Diseases2021 to 2022$2,722,493September 30, 2018September 29, 2023PETROVSKY, NIKOLAIreporter.nih.gov

Funding by fiscal year

Fiscal yearNIH awardsNIH amountNSF awardsNSF amount
20221$1,551,9860$0
20211$1,170,5070$0

Topics of its NIH awards

Updated November 3, 2026. Read from NIH RePORTER ExPORTER and NSF Award Search. Published by NIH and NSF as U.S. government data. NIH awards are fiscal years 2021 to 2025 (NIH files published to 2026-07-09); NSF awards are fiscal years 2022 to 2026 (NSF files published to 2026-11-02). NIH amounts are the total cost of each fiscal year in the window; NSF amounts are the funds obligated in the window. Organizations are matched on the UEI. Open opportunities come from Grants.gov and match on agency and assistance listing number, and on the notice number NIH prints on an award. Free to reuse with credit to SpecStream under CC BY 4.0. Spot a wrong value? Write to [email protected] with the link to this page.